Nath Bio Genes India Ltd vs Shanti Overseas India Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Sep 30, 2026

Key Highlights

The Latest Trading Price of Nath Bio-Genes (India) Ltd is ₹ 142.9 as of 30 Sep 15:30 . The P/E Ratio of Nath Bio-Genes (India) Ltd changed from 7.7 on March 2023 to 0 on March 2026 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Shanti Overseas (India) Ltd changed from 8.5 on March 2022 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 years The Market Cap of Nath Bio-Genes (India) Ltd changed from ₹ 405.45 crore on March 2022 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 yearsThe Market Cap of Shanti Overseas (India) Ltd changed from ₹ 26.27 crore on March 2022 to ₹ 5.72 crore on March 2026 . This represents a CAGR of -22.44% over 6 years The revenue of Nath Bio-Genes (India) Ltd for the Jun '26 is ₹ 331.5 crore as compare to the Mar '26 revenue of ₹ 55.23 crore. This represent the growth of 500.22% The revenue of Shanti Overseas (India) Ltd for the Jun '26 is ₹ 0.27 crore as compare to the Mar '26 revenue of ₹ 5.39 crore. This represent the decline of -94.99% The ebitda of Nath Bio-Genes (India) Ltd for the Jun '26 is ₹ 38.25 crore as compare to the Mar '26 ebitda of ₹ 8.11 crore. This represent the growth of 371.64% The ebitda of Shanti Overseas (India) Ltd for the Jun '26 is ₹ 0.26 crore as compare to the Mar '26 ebitda of ₹ -4.48 crore. This represent the decline of -105% The net profit of Nath Bio-Genes (India) Ltd changed from ₹ 33.35 crore to ₹ 32.26 crore over 9 quarters. This represents a CAGR of -1.47% The net profit of Shanti Overseas (India) Ltd changed from ₹ -0.49 crore to ₹ 0.03 crore over 9 quarters. This represents a CAGR of NaN% The Dividend Payout of Nath Bio-Genes (India) Ltd changed from 6.83 % on March 2021 to 0 % on March 2026 . This represents a CAGR of -100.00% over 6 yearsThe Dividend Payout of Shanti Overseas (India) Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Nath Bio-Genes (India) Ltd

Nath Bio-Genes (India) Limited was originally incorporated in the name and style of 'Shivnath Farms Private Limited' as Private Limited Company which thereafter was converted into Public Limited Company on 13 September, 2000 under the name and style of Shivnath Farms Limited' and further changed from Shivnath Farms Limited to Nath Bio-Genes (India) Limited on March 05, 2001. The Company stands as a distinguished leader in the Indian seed industry, leveraging over two decades of expertise in producing and distributing high-quality seeds to Indian farmers.
The Company's robust research and development initiatives have yielded numerous acclaimed cotton seed varieties, noted for their resilience against viruses and weather fluctuations, as evidenced by their outstanding performance in ICAR trials.

About Shanti Overseas (India) Ltd

Shanti Overseas (India) Limited was originally formed and registered as a partnership firm with the name of 'M/s Shanti Overseas' on 15 November 2004.
Thereafter 'M/s Shanti Overseas' was converted from a partnership firm to a Private Company with the name of 'Shanti Overseas (India) Private Limited' on April 18, 2011.
Subsequently, the Company was converted into a Public Limited Company and the name was changed to 'Shanti Overseas (India) Limited' on 20 January 2017. Shanti Overseas was formed for carrying out the trading business of agri-commodities.
Presently, it is engaged in manufacturing of soya products which includes, soya de-oiled cakes (soya meal), soya crude oil, degummed oil and soya lecithin, and is also involved in primary processing and trading of agri commodities such as chickpeas, soyabeans, cracked corn, maize, yellow peas, pulses etc.

FAQs for the comparison of Nath Bio-Genes (India) Ltd and Shanti Overseas (India) Ltd

Which company has a larger market capitalization, Nath Bio-Genes (India) Ltd or Shanti Overseas (India) Ltd?

Market cap of Nath Bio-Genes (India) Ltd is 271 Cr while Market cap of Shanti Overseas (India) Ltd is 6 Cr

What are the key factors driving the stock performance of Nath Bio-Genes (India) Ltd and Shanti Overseas (India) Ltd?

The stock performance of Nath Bio-Genes (India) Ltd and Shanti Overseas (India) Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Nath Bio-Genes (India) Ltd and Shanti Overseas (India) Ltd?

As of September 30, 2026, the Nath Bio-Genes (India) Ltd stock price is INR ₹142.9. On the other hand, Shanti Overseas (India) Ltd stock price is INR ₹5.49.

How do dividend payouts of Nath Bio-Genes (India) Ltd and Shanti Overseas (India) Ltd compare?

To compare the dividend payouts of Nath Bio-Genes (India) Ltd and Shanti Overseas (India) Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.